Visum Pharmaceuticals
Chengdu, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Ophthalmic biotech creating novel drug and drug-device combination products for front-of-eye diseases.
Ophthalmology
Technology Platform
Proprietary nanoemulsion and gel-based formulation technologies for enhanced ocular drug delivery and bioavailability.
Opportunities
Large addressable markets in chronic ophthalmic conditions where improved drug delivery can command premium pricing.
Risk Factors
High risk of clinical and regulatory setbacks, and difficulty in achieving commercial differentiation in a crowded field.
Competitive Landscape
Enters a highly competitive ophthalmology market dominated by large multinationals and numerous biotechs focusing on novel formulations and delivery systems.